In this conversation, Dr. David Henry, editor-in-chief of Community Oncology, and Dr. Michael Auerbach, clinical professor at Georgetown University School of Medicine, speak about iron therapy and the results of Dr. Auerbach's latest study on the topic. Dr. Auerbach found that ferumoxytol administered as a total dose infusion of 1020 mg in 15 minutes was well tolerated and effective in patients with iron deficiency anemia due to a variety of underlying conditions. If the finding is confirmed through randomized controlled studies, the approach would make intravenous iron administration more convenient for physicians and patients.